Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -151,811 | -121,415 | -76,784 | -45,017 | -171,453 |
| Depreciation Amortization | 10,845 | 8,119 | 5,483 | 2,903 | 8,279 |
| Accounts receivable | 16,839 | 20,080 | 23,971 | 23,468 | -15,941 |
| Accounts payable and accrued liabilities | 787 | -913 | -2,598 | -2,531 | 1,554 |
| Other Working Capital | -12,875 | 2,989 | -16,220 | 8,315 | -6,580 |
| Other Operating Activity | 1,945 | -5,086 | -12,690 | -17,138 | 30,907 |
| Operating Cash Flow | $-134,270 | $-96,226 | $-78,838 | $-30,000 | $-153,234 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -75,069 | -83,942 | -78,350 | -68,817 | 81,598 |
| PPE Investments | -4,289 | -3,042 | -2,262 | -1,675 | -24,954 |
| Investing Cash Flow | $-79,358 | $-86,984 | $-80,612 | $-70,492 | $56,644 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 119,972 | 119,675 | 119,638 | 119,005 | 105,251 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -260 |
| Financing Cash Flow | $119,972 | $119,675 | $119,638 | $119,005 | $104,991 |
| Beginning Cash Position | 220,128 | 220,128 | 220,128 | 220,128 | 211,727 |
| End Cash Position | 126,472 | 156,593 | 180,316 | 238,641 | 220,128 |
| Net Cash Flow | $-93,656 | $-63,535 | $-39,812 | $18,513 | $8,401 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,270 | -96,226 | -78,838 | -30,000 | -153,234 |
| Capital Expenditure | -4,289 | -3,042 | -2,262 | -1,675 | -24,954 |
| Free Cash Flow | -138,559 | -99,268 | -81,100 | -31,675 | -178,188 |